Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

The Canadian cannabis company expects an improving bottom line in future quarters.

Why Tilray's Revenue Soared and Its Loss Widened in Q1

Tilray Inc (TLRY) CEO Brendan Kennedy on Q1 2020 Results - Earnings Call Transcript

Tilray Inc (TLRY) delivered earnings and revenue surprises of -11.36% and 4.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Tilray Inc (TLRY) Reports Q1 Loss, Tops Revenue Estimates

NVIDIA

Penn Entertainment

Datadog

Tilray and Datadog are set to report earnings, while Nvidia and Penn Gaming continue to trade well. So, let's look at a few top stock trades.

4 Top Stock Trades for Tuesday: NVDA, TLRY, DDOG, PENN

Tilray reports after the close today as analysts warn of cascading effects on the industry from coronavirus shutdowns.
The post Tilray Earnings Due As Pot Industry Faces This 'Vicious Cycle' appeared first on Investor's Business Daily.

Tilray Earnings Due As Pot Industry Faces This 'Vicious Cycle'

The stress of quarantine lockdown may be enough to drive a person to drink or drugs.

Why to Keep an Eye on Tilray Stock

The marijuana stock rebounded slightly from the prior month's drubbing.

Why Tilray Stock Gained 17% in April

You don't have to make a social statement in selling TLRY stock. The company's fiscal performance is more than enough reason to sell shares.

Dump Tilray Stock as an Act of Protest

Even with the impact of the novel coronavirus, the cannabis sector offers some positives, which is good news for TLRY stock. However, deciphering which investments will survive makes Tilray a little more suspect.

Will Tilray Be Among the Survivors in the Cannabis Industry?

Cash burn has accelerated and implies further equity dilution in the coming quarters. Slow growth is likely for medicinal cannabis.

Tilray Lacks Positive Triggers on the Horizon

Aphria

Green Thumb Industries Inc.

Neptune Wellness Solutions Inc.

Curaleaf Holdings, Inc.

Finally, pot stock investors have something to cheer about.

The 9 Best Marijuana Stocks in April

Tilray has poor fundamentals and is more than 95% off its highs. Investors should avoid TLRY stock in favor of other cannabis stocks.

Why Investors Should Still Take a Hard Pass on Tilray

Canada-based cannabis company Tilray Inc. TLRY, +0.74% filed Thursday its 2020 Proxy Statement, which shows that Chief Executive Brendan Kennedy got a 35.4% raise in his base salary in 2019, but his total compensation declined nearly 90% as he received no stock option awards.

Tilray CEO Brendan Kennedy gets a 35% raise in base pay in 2019, but total compensation tumbles

Canopy Growth

Both cannabis companies have big-name partners. But one has a lot more of what's most important right now.

Better Marijuana Stock: Canopy Growth vs. Tilray

A bearish technical signal is flashing for Tilray (TLRY) stock

Technical Trouble Ahead For Struggling Pot Stock

Beyond Meat

iShares Russell 2000 ETF

Alibaba

Beyond Meat, the Russell 2000 ETF, Alibaba, Tilray and a preview on UPS earnings were our top stock trades for Tuesday.

5 Top Stock Trades for Tuesday: BABA, TLRY, BYND, IWM, UPS

Big cannabis stocks are rallying on Monday, with many posting double-digits gains.

Why Tilray, Curaleaf, Canopy Growth And Other Cannabis Stocks Are Rallying Today

In 2019, the cannabis producer burned through nearly $400 million in cash.

Is Tilray Running Out of Money?

Some investors could be getting scared out of their shorts with the overall stock market rising.

Why Tilray Stock Jumped 18.2% Higher Today

Aurora Cannabis

Cronos Group

Marijuana stocks have been beaten down during the coronavirus downturn, so let's rank the top four cannabis companies from best to worst.

Ranking the ‘Big 4’ Canadian Marijuana Stocks From Best to Worst

HEXO Corp

These marijuana stocks will not have investors seeing green anytime soon.

3 Pot Stocks to Avoid Like the Plague for the Rest of 2020

In the latest trading session, Tilray, Inc. (TLRY) closed at $6.68, marking a -1.18% move from the previous day.

Tilray, Inc. (TLRY) Stock Moves -1.18%: What You Should Know

Tilray Inc. (NASDAQ: TLRY) has been one of the better pot stocks, but that is not saying much.

Does Tilray Stock Have Enough Cash to Outlast the Market?

Jefferies now believes the struggling Canadian marijuana company is a sell.

Tilray's Stock Falls 6% on Analyst Downgrade

OrganiGram Holdings Inc.

Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability.

News for Tilray Brands Stock (TLRY)